CLINICAL_TRIALS
research
· 2026-02-03
Clinical Trial Update: Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE) [NA]
Summary
A prospective biobanking study by Institut Curie (SCANDARE) aims to understand how tumor molecular alterations relate to the tumor microenvironment and immune r…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Institut Curie | Conditions: Ovarian Cancer, Triple-Negative Breast Cancer | NA | Status: RECRUITING